We are live on
!
Find out more
Vanguard Group Portfolio holdings
AUM
$6.9T
Turnover
4.07%
1-Year Est. Return
27.45%
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
This Fund
S&P 500
This Quarter
Est. Return
+14.09%
1 Year Est. Return
+27.45%
3 Year Est. Return
+121.04%
5 Year Est. Return
+156.26%
10 Year Est. Return
+538.59%
AUM
$6.18T
AUM Growth
+$647B
(+12%)
Cap. Flow
+$78.1B
Cap. Flow
% of AUM
1.26%
Top 10 Holdings %
Top 10 Hldgs %
28.81%
Holding
4,383
New
103
Increased
2,425
Reduced
1,410
Closed
108
Avg Time Held
8.1
years
Top 10 Avg Time Held
4.8
years
Top 20 Avg Time Held
6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$5.95B |
| 2 |
NVIDIA
NVDA
|
+$4.97B |
| 3 |
Capital One
COF
|
+$4.5B |
| 4 |
Amazon
AMZN
|
+$3.45B |
| 5 |
Flutter Entertainment
FLUT
|
+$3.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Discover Financial Services
DFS
|
+$5.32B |
| 2 |
Intra-Cellular Therapies Inc.
ITCI
|
+$1.26B |
| 3 |
Amphenol
APH
|
+$1.18B |
| 4 |
Welltower
WELL
|
+$987M |
| 5 |
US Steel
X
|
+$825M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.14% |
| 2 | Financials | 14% |
| 3 | Consumer Discretionary | 10.14% |
| 4 | Healthcare | 9.38% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3201
Sunrise Realty Trust
SUNS
$87.3M
| $5.24M | ﹤0.01% |
493,926
+1,960
| +0.4% | +$20.3K |
2024 Q3
3 quarters
|
|
3202
M-tron Industries
MPTI
$293M
| $5.23M | ﹤0.01% |
124,470
+18,339
| +17% | +$883K |
2022 Q4
10 quarters
|
|
3203
Inseego
INSG
$73M
| $5.23M | ﹤0.01% |
634,424
+107,063
| +20% | +$837K |
2013 Q2
48 quarters
|
|
3204
Travelzoo
TZOO
$52M
| $5.22M | ﹤0.01% |
409,851
+46,260
| +13% | +$607K |
2013 Q2
48 quarters
|
|
3205
Black Diamond Therapeutics
BDTX
$97.7M
| $5.22M | ﹤0.01% |
2,103,032
-253,801
| -11% | -$489K |
2020 Q1
21 quarters
|
|
3206
Microbot Medical
MBOT
$63.8M
| $5.17M | ﹤0.01% |
2,050,638
+1,309,473
| +177% | +$3.13M |
2019 Q1
25 quarters
|
|
3207
Cartesian Therapeutics
RNAC
$199M
| $5.16M | ﹤0.01% |
496,366
-7,171
| -1% | -$76.4K |
2016 Q2
36 quarters
|
|
3208
Caribou Biosciences
CRBU
$49.8M
| $5.15M | ﹤0.01% |
4,089,866
-432,166
| -10% | -$425K |
2021 Q3
15 quarters
|
|
3209
Maze Therapeutics
MAZE
$1.53B
| $5.15M | ﹤0.01% |
419,613
-246,941
| -37% | -$2.57M |
2025 Q1
1 quarter
|
|
3210
MacroGenics
MGNX
$215M
| $5.1M | ﹤0.01% |
4,213,114
-212,878
| -5% | -$309K |
2013 Q4
46 quarters
|
|
3211
GoPro
GPRO
$237M
| $5.1M | ﹤0.01% |
6,732,501
-913,216
| -12% | -$593K |
2014 Q3
43 quarters
|
|
3212
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $5.07M | ﹤0.01% |
9,374,728
| – | – |
2013 Q2
48 quarters
|
|
3213
AI Financial Corp
AIFC
$55.2M
| $5.07M | ﹤0.01% |
699,876
+146,147
| +26% | +$1.03M |
2021 Q1
17 quarters
|
|
3214
Intellicheck
IDN
$45.4M
| $5.07M | ﹤0.01% |
940,659
-9,208
| -1% | -$35.2K |
2013 Q2
48 quarters
|
|
3215
Twin Disc
TWIN
$369M
| $5.04M | ﹤0.01% |
571,142
-64,423
| -10% | -$476K |
2013 Q2
48 quarters
|
|
3216
Montana Technologies Corp
AIRJ
$235M
| $5.04M | ﹤0.01% |
1,088,881
+132,553
| +14% | +$609K |
2024 Q2
4 quarters
|
|
3217
Virgin Galactic
SPCE
$391M
| $5.04M | ﹤0.01% |
1,845,653
+268,277
| +17% | +$821K |
2019 Q4
22 quarters
|
|
3218
Sanara MedTech
SMTI
$322M
| $5M | ﹤0.01% |
175,983
-20,483
| -10% | -$614K |
2020 Q4
18 quarters
|
|
3219
CF Bankshares
CFBK
$218M
| $4.99M | ﹤0.01% |
208,104
+58,073
| +39% | +$1.33M |
2014 Q3
43 quarters
|
|
3220
TuHURA Biosciences
HURA
$117M
| $4.98M | ﹤0.01% |
2,234,240
+358,707
| +19% | +$1.21M |
2023 Q3
7 quarters
|
|
3221
Nuvectis Pharma
NVCT
$618M
| $4.98M | ﹤0.01% |
666,805
+199,386
| +43% | +$1.81M |
2022 Q2
12 quarters
|
|
3222
Design Therapeutics
DSGN
$656M
| $4.96M | ﹤0.01% |
1,471,574
+44,107
| +3% | +$165K |
2021 Q1
17 quarters
|
|
3223
Union Bankshares
UNB
$113M
| $4.91M | ﹤0.01% |
184,566
+33,297
| +22% | +$1.01M |
2013 Q4
46 quarters
|
|
3224
The ONE Group
STKS
$44.7M
| $4.91M | ﹤0.01% |
1,212,986
-137,870
| -10% | -$474K |
2016 Q4
34 quarters
|
|
3225
NioCorp Developments
NB
$475M
| $4.87M | ﹤0.01% |
2,091,129
+1,031,540
| +97% | +$2.57M |
2023 Q2
8 quarters
|
|
Similar funds
Vanguard Group's Q2 2025 Portfolio in Review
As of Q2 2025, Vanguard Group held 4,383 positions worth $6.18T, up 12% from $5.53T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Trading was light in Q2 2025: portfolio turnover was 4.8%. Vanguard Group opened 103 new positions and exited 108, leaving the 4,383-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Financials and Consumer Discretionary.
- Vanguard Group's largest Q2 2025 buy was Amrize Ltd: 21,350,540 shares worth $1.07B.
- Vanguard Group added most to Microsoft in Q2 2025, an estimated $5.95B increase.
- Vanguard Group's biggest Q2 2025 reduction was Amphenol, cutting an estimated $1.18B.
- Vanguard Group fully exited Discover Financial Services in Q2 2025, selling an estimated $5.32B.
- Vanguard Group's ten largest holdings make up 29% of its $6.18T portfolio in Q2 2025.
- Vanguard Group opened 103 new positions and closed 108 in Q2 2025.
- Vanguard Group's portfolio value rose 12% quarter-over-quarter to $6.18T.
Based on Vanguard Group's 13F filing for Q2 2025, filed 11 Aug 2025.